[HTML][HTML] An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?

JS Hopstaken, JGR Bomers, MJP Sedelaar, M Valerio… - European Urology, 2022 - Elsevier
Context Focal therapy is a promising, minimally invasive strategy to selectively treat
localized prostate cancer. A previous systematic review indicated that there is growing …

Benefits and risks of primary treatments for high-risk localized and locally advanced prostate cancer: an international multidisciplinary systematic review

L Moris, MG Cumberbatch, T Van den Broeck… - European urology, 2020 - Elsevier
Context The optimal treatment for men with high-risk localized or locally advanced prostate
cancer (PCa) remains unknown. Objective To perform a systematic review of the existing …

Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year …

D Reddy, M Peters, TT Shah, M van Son, MB Tanaka… - European Urology, 2022 - Elsevier
Background Focal therapy aims to treat areas of cancer to confer oncological control whilst
reducing treatment-related functional detriment. Objective To report oncological outcomes …

Focal therapy in primary localised prostate cancer: the European Association of Urology position in 2018

HG van der Poel, RCN van den Bergh, E Briers… - European urology, 2018 - Elsevier
Radical treatment of localised prostate cancer is recognised to be an unnecessary
intervention or overtreatment in many men. Consequently, there has been a rapid uptake in …

Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry

TT Shah, M Peters, D Eldred-Evans, S Miah, T Yap… - European urology, 2019 - Elsevier
Background Focal cryotherapy can be used to treat patients with clinically significant
nonmetastatic prostate cancer to reduce side effects. Objective Early-medium-term cancer …

Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary …

A Stabile, C Orczyk, F Hosking‐Jervis… - BJU …, 2019 - Wiley Online Library
Objective To report medium‐term oncological outcomes in men receiving primary focal
treatment with high‐intensity focused ultrasonography (HIFU) for prostate cancer (PC a) …

Standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer: an international …

AH Lebastchi, AK George, TJ Polascik, J Coleman… - European urology, 2020 - Elsevier
Background Focal therapy (FT) and partial gland ablation (PGA) are quickly adopted by
urologists and radiologists as an option for the management of localized prostate cancer …

French AFU Cancer Committee Guidelines-Update 2022-2024: prostate cancer-Diagnosis and management of localised disease

G Ploussard, G Fiard, E Barret, L Brureau… - Progrès en Urologie, 2022 - Elsevier
Objective The objective of the French Urology Association Cancer Committee is to propose
an update of the recommendations for the diagnosis and management of prostate cancer …

Recommandations françaises du Comité de cancérologie de l'AFU–actualisation 2020–2022: cancer de la prostate

F Rozet, P Mongiat-Artus, C Hennequin, JB Beauval… - Progrès en Urologie, 2020 - Elsevier
Objective.-The purpose of the guidelines national committee ccAFU was to propose updated
french guidelines for prostate cancer. Methods.-A Medline search was achieved between …

Prostate‐specific membrane antigen positron emission tomography in addition to multiparametric magnetic resonance imaging and biopsies to select prostate cancer …

B Geboers, D Meijer, W Counter, A Blazevski… - BJU …, 2024 - Wiley Online Library
Objective To evaluate the additional value of prostate‐specific membrane antigen positron
emission tomography (PSMA‐PET) to conventional diagnostic tools to select patients for …